Utilizing Extracellular Matrix to Enhance Multicellular Tumor Spheroid Models for Proliferation and Invasion

This program is free, please fill in your complete data: Zoom link and other information will be sent to your email, please write your email correctly. If you want to follow information updates related to bioinformatics.

Digital transformation has affected the clinical phase of the drug development journey by improving efficiencies, patient engagement and allowing for utilization of computational and other technologies. This track will address topics such as data collection, flow, storage and analytics and digital transformation case studies in clinical phase and the potential for digital transformation in the preclinical phase. Preclinical in vivo phase is in the initial stages of engaging with digitization and digitalization, which presents opportunities for learning from clinical colleagues how to implement these technologies.

As the prevalence of diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that will aid in the diagnosis and management of patients. This is a complex process that poses challenges for patients, physicians, hospitals and laboratories. What is changing in today’s world is that many hospitals are being asked to take steps toward improving proactive and preventive care, improving patient outcomes while also saving on healthcare costs associated with diabetes and diabetes complications. Laboratories are invaluable partners in addressing this challenge.

Proteins are the molecular workhorses of life. In order for them to perform their physiological function, they need to be folded into unique 3D structures.